MRI-Targeted Biopsy in Prostate Cancer Screening
Prostate cancer screening using prostate-specific antigen testing and standard systematic, transrectal, ultrasonography-guided biopsy reduces mortality from prostate cancer — but comes with serious limitations, including frequent overdiagnosis, overtreatment of clinically insignificant cancers, and unnecessary biopsies. Magnetic resonance imaging with targeted biopsy for MRI-positive findings might improve diagnostic accuracy and reduce unnecessary biopsies. New research findings are summarized in a short video.
Copyright © 2021 Massachusetts Medical Society.
